CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+7.7%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.72B
AUM Growth
+$403M
(+7.6%)
Cap. Flow
+$55.5M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
15.98%
Holding
775
New
66
Increased
305
Reduced
281
Closed
46
Top Buys
| 1 |
Microsoft
MSFT
|
+$45.2M |
| 2 |
Procter & Gamble
PG
|
+$30.3M |
| 3 |
Baidu
BIDU
|
+$29.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$24.2M |
| 5 |
Eli Lilly
LLY
|
+$23M |
Top Sells
| 1 |
GE Aerospace
GE
|
+$29.4M |
| 2 |
SPLS
Staples Inc
SPLS
|
+$26.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$25.3M |
| 4 |
Motorola Solutions
MSI
|
+$24.5M |
| 5 |
Amgen
AMGN
|
+$23.9M |
Sector Composition
| 1 | Healthcare | 27.14% |
| 2 | Technology | 13.78% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.45% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Manulife Financial
MFC
$52.4B
| $3.21M | 0.06% |
158,488
+2,514
| +2% | +$50.9K |
|
352
Ultragenyx Pharmaceutical
RARE
$3.04B
| $3.2M | 0.06% |
60,000
| – | – |
|
353
Ecolab
ECL
$76.8B
| $3.19M | 0.06% |
24,812
+2,366
| +11% | +$304K |
|
|
GHDX
354
DELISTED
Genomic Health, Inc.
GHDX
| $3.18M | 0.06% |
99,000
| – | – |
|
355
Boston Scientific
BSX
$160B
| $3.14M | 0.05% |
107,466
+8,598
| +9% | +$251K |
|
356
Enbridge
ENB
$105B
| $3.1M | 0.05% |
74,370
+8,486
| +13% | +$354K |
|
|
GBT
357
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.01M | 0.05% |
97,000
+14,000
| +17% | +$435K |
|
358
CytomX Therapeutics
CTMX
$345M
| $3M | 0.05% |
165,000
-30,000
| -15% | -$545K |
|
359
Northern Trust
NTRS
$24.6B
| $2.98M | 0.05% |
32,430
-16,462
| -34% | -$1.51M |
|
360
Cognizant
CTSH
$34.6B
| $2.98M | 0.05% |
41,050
+1,686
| +4% | +$122K |
|
361
Fiserv
FI
$74.2B
| $2.98M | 0.05% |
46,150
+5,762
| +14% | +$372K |
|
|
GWPH
362
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.94M | 0.05% |
29,000
+5,000
| +21% | +$507K |
|
|
AKAO
363
DELISTED
Achaogen, Inc.
AKAO
| $2.91M | 0.05% |
182,555
-18,000
| -9% | -$287K |
|
364
Intercontinental Exchange
ICE
$99.3B
| $2.91M | 0.05% |
42,325
+3,107
| +8% | +$213K |
|
365
Acadia Pharmaceuticals
ACAD
$4.19B
| $2.9M | 0.05% |
77,000
-50,000
| -39% | -$1.88M |
|
366
Revvity
RVTY
$9.87B
| $2.9M | 0.05% |
42,000
| – | – |
|
|
AERI
367
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.87M | 0.05% |
59,000
+19,000
| +48% | +$923K |
|
368
The Mosaic Company
MOS
$10.2B
| $2.83M | 0.05% |
130,850
-156,243
| -54% | -$3.37M |
|
369
Ametek
AME
$43.3B
| $2.81M | 0.05% |
42,548
+30,368
| +249% | +$2.01M |
|
370
ODP
ODP
$621M
| $2.81M | 0.05% |
61,872
| – | – |
|
371
General Mills
GIS
$26.9B
| $2.81M | 0.05% |
54,239
-14,767
| -21% | -$764K |
|
372
TherapeuticsMD
TXMD
$12.5M
| $2.8M | 0.05% |
10,600
+1,000
| +10% | +$265K |
|
|
ITCI
373
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.79M | 0.05% |
177,000
+22,000
| +14% | +$347K |
|
374
Halozyme
HALO
$8.9B
| $2.76M | 0.05% |
159,000
-83,000
| -34% | -$1.44M |
|
375
VF Corp
VFC
$5.95B
| $2.76M | 0.05% |
46,100
-11,804
| -20% | -$707K |
|